Molecular mechanisms of hereditary progressive dystonia with marked diurnal fluctuation, Segawa's disease
- PMID: 10984669
- DOI: 10.1016/s0387-7604(00)00136-4
Molecular mechanisms of hereditary progressive dystonia with marked diurnal fluctuation, Segawa's disease
Abstract
The causative gene for hereditary progressive dystonia with marked diurnal fluctuation/dopa-responsive dystonia (HPD/DRD) was discovered in 1994 to be guanosine triphosphate (GTP) cyclohydrolase I, an enzyme involved in tetrahydrobiopterin biosynthesis. To the present, more than 50 mutations have been found in this gene in HPD/DRD patients. Although it is clear that HPD/DRD is caused by partial deficiency of tetrahydrobiopterin in the brain, several important issues regarding the molecular etiology of HPD/DRD remain to be addressed. We review herein the recent progress in the molecular genetics of HPD/DRD and clarify the points to be answered.
Similar articles
-
[Hereditary progressive dystonia with marked diurnal fluctuation; dominant Dopa-responsive dystonia linked to GTP cyclohydrolase I gene (HPD/DRD); Segawa's disease].Ryoikibetsu Shokogun Shirizu. 1999;(27 Pt 2):144-7. Ryoikibetsu Shokogun Shirizu. 1999. PMID: 10434614 Review. Japanese. No abstract available.
-
Molecular genetics of dopa-responsive dystonia.Biol Chem. 1999 Dec;380(12):1355-64. doi: 10.1515/BC.1999.175. Biol Chem. 1999. PMID: 10661862 Review.
-
[Molecular genetics of hereditary progressive dystonia (HPD/Segawa's disease)].Nihon Rinsho. 1996 May;54(5):1453-9. Nihon Rinsho. 1996. PMID: 8965384 Review. Japanese.
-
Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene.Nat Genet. 1994 Nov;8(3):236-42. doi: 10.1038/ng1194-236. Nat Genet. 1994. PMID: 7874165
-
[Molecular biology of hereditary dystonia].No To Hattatsu. 1998 Mar;30(2):93-100. No To Hattatsu. 1998. PMID: 9545771 Review. Japanese.
Cited by
-
Clinical Features, Neuroimaging, and Levodopa-Responsiveness in Holmes' Tremor: A Video-Based Case-Series with a Review of the Literature.Mov Disord Clin Pract. 2022 Jul 7;9(6):805-815. doi: 10.1002/mdc3.13501. eCollection 2022 Aug. Mov Disord Clin Pract. 2022. PMID: 35937478 Free PMC article. Review.
-
DYT-TOR1A dystonia: an update on pathogenesis and treatment.Front Neurosci. 2023 Aug 10;17:1216929. doi: 10.3389/fnins.2023.1216929. eCollection 2023. Front Neurosci. 2023. PMID: 37638318 Free PMC article. Review.
-
Dopa-responsive dystonia: functional analysis of single nucleotide substitutions within the 5' untranslated GCH1 region.PLoS One. 2013 Oct 4;8(10):e76975. doi: 10.1371/journal.pone.0076975. eCollection 2013. PLoS One. 2013. PMID: 24124602 Free PMC article.
-
The neurobiological basis for novel experimental therapeutics in dystonia.Neurobiol Dis. 2019 Oct;130:104526. doi: 10.1016/j.nbd.2019.104526. Epub 2019 Jul 4. Neurobiol Dis. 2019. PMID: 31279827 Free PMC article. Review.
-
Primary dystonia: molecules and mechanisms.Nat Rev Neurol. 2009 Nov;5(11):598-609. doi: 10.1038/nrneurol.2009.160. Epub 2009 Oct 13. Nat Rev Neurol. 2009. PMID: 19826400 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical